Tuesday, December 23, 2008 2:38:02 AM
http://www.fool.com/investing/international/2008/12/19/5-star-stocks-poised-to-pop-guangshen-railway.aspx
Brian D. Pacampara
December 19, 2008
Based on the aggregated intelligence of 120,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, Chinese railroad operator Guangshen Railway (NYSE: GSH) has earned a coveted five-star ranking. Our data has shown that five-star stocks outperform the market by a significant margin; conversely, one-star stocks have woefully lagged the market average.
With that in mind, let's take a closer look at Guangshen's business and see what CAPS investors are saying about the stock right now.
Guangshen facts
Headquarters (Founded)
Shenzhen, China (1996)
Market Cap
$2.65 Billion
Industry
Railroads
Trailing-12-Month Revenue
$1.72 Billion
Management
Chairman He Yuhua (Since June 2007)
General Manager Shen Yi (Since October 2008)
Return on Equity (Average, Past Three Years)
5.8%
Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.
On CAPS, 521 of the 538 members who have rated Guangshen -- some 97% -- believe the stock will outperform the S&P 500 going forward. These Foolish bulls include CAPS All-Star Theresewin and coregonus.
Last week, Theresewin urged our community to ride Guangshen all the way to gains: "[Get] on board while you still can ... China NEEDS its rail system to better integrate its country and is investing big bucks to do so!"
In a pitch from last month, coregonus agreed and elaborated on the strong long-term trends supporting the stock:
Backing up my faith in railways, and that China is totally committed to rail in the long term -- if you have ever ridden their hi speed mag-lev train in Shanghai you get the depth of their commitment -- they know not everyone will have cars, it would not work there. As more cities get built out, trains will too -- and at the end there are real assets in the train business and freight on rail has very long legs (or tracks).
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM